8E6C
Crystal structure of MERS 3CL protease in complex with a m-fluorophenyl dimethyl sulfane inhibitor
Summary for 8E6C
Entry DOI | 10.2210/pdb8e6c/pdb |
Descriptor | Orf1a protein, [2-(3-fluorophenyl)sulfanyl-2-methyl-propyl] ~{N}-[(2~{S})-1-[[3-[(3~{S})-2-$l^{3}-oxidanylidenepyrrolidin-3-yl]-1-$l^{1}-oxidanylsulfonyl-1-oxidanyl-propan-2-yl]-$l^{2}-azanyl]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate (3 entities in total) |
Functional Keywords | protease, protease inhhibitors, hydrolase, viral protein-inhibitor complex, viral protein/inhibitor |
Biological source | Middle East respiratory syndrome-related coronavirus |
Total number of polymer chains | 1 |
Total formula weight | 34891.93 |
Authors | Liu, L.,Lovell, S.,Battaile, K.P.,Dampalla, C.S.,Groutas, W.C. (deposition date: 2022-08-22, release date: 2022-09-07, Last modification date: 2024-05-01) |
Primary citation | Dampalla, C.S.,Miller, M.J.,Kim, Y.,Zabiegala, A.,Nguyen, H.N.,Madden, T.K.,Thurman, H.A.,Machen, A.J.,Cooper, A.,Liu, L.,Battaile, K.P.,Lovell, S.,Chang, K.O.,Groutas, W.C. Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV). Eur.J.Med.Chem., 254:115376-115376, 2023 Cited by PubMed: 37080108DOI: 10.1016/j.ejmech.2023.115376 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.7 Å) |
Structure validation
Download full validation report